PENTAX Medical Americas’ Post

We recently finished a live case treating Barrett's esophagus: Impressive treatment performed by Dr. Vinay Sehgal using PENTAX Medical C2 CryoBalloon™ ablation. As nicely demonstrated, it is a safe and effective procedure, and it is easy to use by both the physician and the staff. As shown, it can effectively eradicate esophageal dysplasia and metaplasia, ultimately reducing the risk of developing esophageal cancer*. #PENTAXMedical #CryoBalloon #Innovation * Reference: 1) Frederiks C. N., et al., Comparison of focal cryoballoon ablation with 10- and 8-second

We recently finished a live case treating Barrett's esophagus: Impressive treatment performed by Dr. Vinay Sehgal using PENTAX Medical C2 CryoBalloon™ ablation. As nicely demonstrated, it is a safe and effective procedure, and it is easy to use by both the physician and the staff. As shown, it can effectively eradicate esophageal dysplasia and metaplasia, ultimately reducing the risk of developing esophageal cancer*. #PENTAXMedical #CryoBalloon #Innovation * Reference: 1) Frederiks C. N., et al., Comparison of focal cryoballoon ablation with 10- and 8-second

Thanks to the EORTC - European Organisation for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group for the opportunity to present earlier today at the Autumn Meeting 2024 in Turin, Italy!   Sébastien Coppe, PhD and Pascal Piedbois presented "New endpoints for clinical trials: Net Treatment Benefit" and how this can improve understanding of treatment effects. The Net Treatment Benefit integrates multiple outcomes into a single patient-centric endpoint, offering a multidimensional approach to estimate and report treatment effects. This is especially useful in rare cancer trials, where identifying a single outcome is challenging, and it helps reduce sample sizes.   It was great to exchange insights with fellow researchers and clinicians!   #EORTC #ClinicalTrials #NetTreatmentBenefit #PatientOutcomes

Poster 2 of 3 Hemant Rathi would be presenting our research titled: “Real-World Effectiveness and Safety of First-Line Pembrolizumab Monotherapy for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis” at #ISPORAnnual Co- authors: Geetank Kamboj, Aastha Radotra, PARINITA BARMAN, Shirish Dongare, PhD, Surabhi Aggarwal, Hemant Rathi #ISPOR2024 #HEOR #SkywardAnalytics #LiteratureReviews #SLR #MetaAnalysis

❗️Drs. Suneel Kamath, Arvind Dasari, and Sakti Chakrabarti discuss the management of oligometastatic #colorectal cancer in a roundtable moderated by Dr. Shikha Jain: https://buff.ly/4eNZ9No 👉 The panel emphasizes the importance of a multidisciplinary approach, local therapies, and tailored treatments.

🆕#IARCpaper in The Lancet aims to evaluate which #HPV genotypes caused #CervicalCancer, as well as their carcinogenic strength and contribution to burden of #CxCa. Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature: https://lnkd.in/dAGfNnYy

A single piece of dried blood could be all that is needed for a new AI-powered test that can swiftly and effectively identify three main forms of cancer one day. In early trials, the instrument demonstrated the ability to discriminate between those without cancer and those with confirmed pancreatic, gastric, or colorectal cancer and the analytic process took only a few minutes, according to Live Science. #AI #artificialintelligence #NewsUpdate #pakstream #pakistan

#ICYMI: MAIA recently released key achievements year-to-date, including #clinical progress for lead candidate THIO, a potential first-in-class cancer telomere targeting agent in clinical development, to evaluate its activity in #NSCLC. Read more: https://bit.ly/4bNqiy7

Back to School: Cell Division - The Cell Cycle In this lesson, we'll be looking at the cell cycle, which describes the sequence of cell growth and division. The regulation of the cell cycle is critical, as any errors can lead to uncontrolled cell division, contributing to the development of cancer. #BiologyLesson #NarratedBiologyAnimations #NMAL #CellCycle The Cell Lesson 9: https://nmm.fyi/sps4sjli

Cancer escapes immunotherapies by mutating its surface. This means even groundbreaking #CARTCell therapies fail too often because of cancer resistance. But what if we could use #GenerativeAI to design CAR-T with de novo binders faster and smarter, targeting even resistant tumors? In the first preprint from my and Julian Grünewald lab @TU_Muenchen, we show how this could work for new #celltherapies and #genetherapies. (1) 🧵https://lnkd.in/dGVPnz3G